TRANSTHERA-B(02617): Feng Weibo appointed as an independent non-executive director.
YaoJianKang-B (02617) announced that, with the approval of the shareholders' annual meeting, Mr. Feng Weibo has been appointed as an independent non-executive director of the second board of directors, effective from June 18, 2026, until the expiration of the term of office of the second board of directors. At the same time, Mr. Feng Weibo has been appointed as the chairman of the board's compensation and assessment committee, as well as a member of the board's audit committee and nomination committee. In addition, Ms. Zheng ZheLan will no longer serve as an independent non-executive director of the company after the shareholders' annual meeting, and will no longer serve as the chairman of the compensation and assessment committee, as well as a member of the audit committee and nomination committee.
TRANSTHERA-B (02617) has announced that Mr. Feng Weibo has been appointed as an independent non-executive director of the second board of directors, effective from June 18, 2026, until the end of the term of the second board of directors. Mr. Feng Weibo has also been appointed as the chairman of the board's remuneration and assessment committee, as well as a member of the audit committee and nomination committee. Additionally, Ms. Zheng Zhelan will no longer serve as an independent non-executive director of the company after the annual general meeting of shareholders, and will no longer serve as the chairman of the remuneration and assessment committee or as a member of the audit committee and nomination committee.
Related Articles

On June 18, JIUYUAN GENE (02566) spent 113,900 Hong Kong dollars to repurchase 19,600 shares.

Partial shareholders of Shanghai Aladdin Biochemical Technology Co., Ltd. (688179.SH) plan to reduce their holdings in the company.

HXTL (01085) Subsidiary Xinkeixin Signs Guarantee Contract
On June 18, JIUYUAN GENE (02566) spent 113,900 Hong Kong dollars to repurchase 19,600 shares.

Partial shareholders of Shanghai Aladdin Biochemical Technology Co., Ltd. (688179.SH) plan to reduce their holdings in the company.

HXTL (01085) Subsidiary Xinkeixin Signs Guarantee Contract

RECOMMEND





